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Predictors and impact of in-hospital recurrent
myocardial infarction in acute coronary syndrome
patients: Findings from Gulf RACE-2
A. Al-Saleh, A. Hersi, K.F. Alhabib, A.A. Alsheikh-
Ali, K. Sulaiman, H. Alfaleh, S. Alsaif, W.
Almahmeed, N. Asaad, H. Amin, A. Al-Motarreb,
J. Al Suwaidi
Introduction: Little in the literature is known about
the predictors and the adverse impact of recurrent ische-
mia and infarction in patients with acute coronary syn-
drome (ACS). Accordingly; our objectives were to
determine the risk factors, and long term outcome of
patients with recurrent ischemia.
Methods: We evaluated ACS patients who were
enrolled in the second Gulf Registry of Acute Coronary
Events (Gulf RACE-2).
Results: Out of 7930 ACS patients, 172 (2.2%) devel-
oped recurrent myocardial infarction (Re-MI) during
their hospitalization. Patients with Re-MI were more
likely to be older (mean age 59.12 ± 13.5 vs. 56.8 ± 12.4;
P = 0.016), had higher rates of hyperlipidemia (41.3% vs.
32.6%; P = 0.027) and previous angina (47.7% vs. 37.9%;
P = 0.006), presented more with STEMI (72.1% vs. 43.9%;
P < 0.001), and had more Killip class 4 upon admission
(8.1% vs. 3.2%; P < 0.001) than patients without Re-MI.
Management-wise, Re-MI patients received less aspirin
(94.8% vs. 98.5%; P = 0.002), beta-blockers (59.3% vs.
74.7%; P < 0.001), and statin (87.2% vs. 94.9%; P < 0.001),
and were less frequently assessed by coronary angio-
gram (30.8% vs. 32.5%; P = 0.036). These patients had
more in-hospital complications including congestive
heart failure (44.2% vs. 12.4%) and cardiogenic shock
(25.6% vs. 5.3%) as well as higher mortality rates; both
during hospitalization (23.8% vs. 4.1%) and after a dis-
charge period of 30 days (27.3% vs. 6.87%) and 1 year
(29.1% vs. 9.3%). P < 0.001 for all comparisons.
Conclusion: Patients with recurrent infarction have a
bad prognosis in terms of in-hospital complications and
high mortality rates. High risk patients need to be moni-
tored and managed differently to prevent secondary
attacks.
http://dx.doi:10.1016/j.jsha.2012.06.191
Effect of body weight on the outcome of ventric-
ular septal defect repair
Ahmad I. Aldughiem, Sameh R. Ismail, Riyadh M.
Abu-Sulaiman, Mohamed S. Kabbani, Hani K.
Najm
Introduction: Low body weight and failure to thrive
(FTT) often are considered limiting factors for open heart
surgery. The purpose of our study is to asses the impact
of FTT on ICU outcome of children undergoing ventricu-
lar septal defect repair.
Methods: We conducted a retrospective chart review
analysis of all children who had VSD closure by open
heart surgery during the period 2002–2010. Children were
divided into two groups based on their weight for age
using standard growth charts. Those with normal or mild
failure to thrive (Z score > 3) are labeled as group A.
Group B included all children with severe failure to
thrive (Z score 6 3). Both groups were compared in
term of early post operative course.
Results: One hundred and forty-five patients under-
went open heart surgery for VSD closure during the
study period. There were 58 cases in group A and 87
patients in group B. The age and weight in group A
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was (8 ± 5.16 months) and (6.31 ± 1.75 kg), respectively.
The age and weight in group B was (7.6 ± 3.9 months)
and (4.84 ± 1.12) kg, respectively. There were no signifi-
cant differences between the two groups in terms of post
operative course, and major complications.
Conclusion: Failure to thrive was not associated with
increase in ICU morbidity and mortality in children
undergoing VSD closure. Attempt to optimize the body
weight for age in children with CHD may not add any
beneficial advantages in term of surgical risk or postoper-
ative ICU outcome.
http://dx.doi:10.1016/j.jsha.2012.06.192
Impact of obesity on survival and New York Heart
Association functional class in patients with sys-
tolic heart failure
Alaa Tayiem
Background: Several studies have shown that in
patients with heart failure (HF), obesity is not associated
with increased mortality, but rather is associated with
improved survival. This has been referred to as the
‘‘obesity paradox’’.
Objective: To examine the impact of body mass
index (BMI) on survival and New York Heart Association
(NYHA) functional class in a Saudi outpatient population
with chronic systolic HF.
Method: This retrospective, descriptive study, ana-
lyzed data from patients with chronic systolic HF and
ejection fraction less than or equal 40% attending a Car-
diovascular Disease Management program (CVDMP)
over a mean follow-up of 48 months.
Patients were classified according to their baseline
BMI. Continuous variables were presented as mean
and frequencies while categorical variable presented as
percentages.
Risks associated with BMI groups were evaluated
using multinomial logistic regression model.
Results: Mortality in the total population (n = 903)
was 3.3% where 47% were above age of 60 and 77% were
male. Significant co-morbidities included; 67% diabetes
mellitus, 67% hypertension, 12% bronchial asthma, 11%
thyroid problems, 6% renal failure and 36% of patients
had an EF less than 25%.
BMI showed significant increase in the last follow-up
compared to baseline (p < 0.000). Obesity, measured by
BMI, showed no statistical impact on mortality
(p < 0.319), but did significantly impact NYHA functional
class (p < 0.023).
Conclusion: There was a chronological increase in
BMI, and, although this had no significant impact on
mortality, it had a significant negative impact on NYHA
functional class.
http://dx.doi:10.1016/j.jsha.2012.06.193
Improvement of mitral regurgitation after trans-
catheter aortic valve implantation (TAVI)
Husain Alamri, Ali Almasood, Saeed Alahmari,
Saad Alkasab, Mohamed Alotaibi, Abdulrahman
Almoghairi, Moheeb Alabdalah
Objectives: To assess the change in mitral regurgita-
tion (MR) severity after transcatheter aortic valve implan-
tation (TAVI).
Background: Mitral regurgitation (MR) is frequently
present in patients with calcific aortic stenosis (AS). Fol-
lowing surgical aortic valve replacement, improvement
in MR is reported in 27–82% of the patients. The changes
in MR severity following TAVI are unknown.
Methods: From April 2009 to January 2011, 57
patients with severe symptomatic aortic stenosis under-
went TAVI [40 cases Edwards Sapien valve (Edwards
Lifesciences Inc, Irvine CA), and 17 cases the CoreValve
ReValving System]. Transthoracic echocardiography
was performed before and 3 months after successful
TAVI procedure. MR was assessed by expert readers
and by color flow mapping and was graded as none
(grade 0), mild (grade 1), moderate (grade 2), moderately
severe (grade 3) or severe (grade 4).
Results: The mean MR grade was 1.7 ± 1.0 and
0.9 ± 0.7 pre- and post-TAVI respectively (p
value < 0.001). MR pretreatment was grade 0–1, grade 2,
and grade 3–4 in 69%, 19%, and 12% of the patients,
respectively. Six patients out of 7 ( 85%) with grade 3–4
demonstrated improvement (4 patients (57%) improved
to mild, and 2 patients (28%) to moderate MR). Seven
patients out of 11 (63%) with grade 2 demonstrated an
improvement to grade 0–1. There was no association
between the improvement of MR and the type of valve
used.
Conclusions: MR improved significantly after TAVI
for severe AS. Further study with careful echocardio-
graphic evaluation of the mitral valve prior to TAVI
may help to predict which patients should experience
an improvement in their MR.
http://dx.doi:10.1016/j.jsha.2012.06.194
Catheter intervention for branch and crossed pul-
monary arteries
Ali Al Akhfash, Mansour Al Mutairi, Omar
Tamimi, Fahad Al Habshan
Introduction: Over the last decade, stent implanta-
tion has become a widely accepted, effective therapy for
the treatment of pulmonary arterial (PA) stenoses. Stent
implantation has proved to be a safe procedure with min-
imal complications.
Objectives: To review our experience with branch
PA stenting. We reviewed also catheter based interven-
tions for patients with right aortic arch and crossed pul-
monary arteries associated with branch PA stenosis.
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